Provided by Tiger Trade Technology Pte. Ltd.

ImmunityBio, Inc.

9.44
+0.61006.91%
Post-market: 9.520.0800+0.85%19:59 EDT
Volume:27.29M
Turnover:263.21M
Market Cap:10.00B
PE:-9.55
High:10.09
Open:8.92
Low:8.90
Close:8.83
52wk High:12.43
52wk Low:1.95
Shares:1.06B
Float Shares:407.00M
Volume Ratio:2.87
T/O Rate:6.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9887
EPS(LYR):-0.3820
ROE:78.05%
ROA:-30.54%
PB:-9.56
PE(LYR):-24.71

Loading ...

Immunitybio Q2 Revenue USD 51.24 Million VS. Ibes Estimate USD 49.7 Million

THOMSON REUTERS
·
Aug 04

Immunitybio Q2 EPS USD -0.22

THOMSON REUTERS
·
Aug 04

ImmunityBio Wins UAE Marketing Authorization for Anktiva in BCG-unresponsive Bladder Cancer

Reuters
·
Jul 30

Movement Alert|ImmunityBio, Inc. Declines 5.02% in Regular Trading, Trading at $7.675

Market Focus
·
Jul 23

Movement Alert|ImmunityBio Rises 5.34% in Regular Trading, Trading at $7.8601

Market Focus
·
Jul 21

Movement Alert|ImmunityBio Falls 5.11% in Regular Trading, Biotech Sector Profit-Taking Drives Continued Rotation Out of High-Beta Small Caps

Market Focus
·
Jul 17

Squeeze Watch: 10 Stocks Bears Love to Hate Most Right Now

Benzinga
·
Jul 14

Movement Alert|ImmunityBio Falls 5.17% in Regular Trading, Biotech Sector Profit-Taking Triggers Broad Pullback

Market Focus
·
Jul 14

Movement Alert|ImmunityBio Intraday Decline 5.58% in Regular Trading, Trading at $8.34

Market Focus
·
Jul 10

Movement Alert|ImmunityBio Falls 5.05% in Regular Trading, Trading at $8.475

Market Focus
·
Jul 07

Immunitybio Director Christobel Selecky Disposes of 159,478 Common Shares Worth $1.44 Million

Reuters
·
Jul 07

Movement Alert|ImmunityBio Falls 5.16% in Regular Trading, Trading at $8.685

Market Focus
·
Jul 06

Immunitybio Director Christobel Selecky Disposes of 96,722 Common Shares Worth $870,677.29

Reuters
·
Jul 02

Immunitybio Director Barry J. Simon Disposes of 25,000 Common Shares Worth $196,907.50

Reuters
·
Jun 27

Movement Alert|ImmunityBio Rises 5.65% in Regular Trading, Rebounds After Digesting FDA Warning Letter Pressure

Market Focus
·
Jun 17

Movement Alert|ImmunityBio Falls 5.12% in Regular Trading, FDA Warning Letter Continues to Suppress Market Confidence

Market Focus
·
Jun 17

ImmunityBio shareholders re-elect nine directors at annual meeting

Reuters
·
Jun 11

3 Growth Companies With High Insider Ownership Seeing Up To 94% Earnings Growth

Simply Wall St.
·
Jun 09

Movement Alert|ImmunityBio Rises 5.06% in Regular Trading, ASCO Clinical Data and Guideline Inclusion Fuel Rebound

Market Focus
·
Jun 09

ImmunityBio director Barry J. Simon sells 23,033 common shares worth $165,284

Reuters
·
Jun 06